The global Drug Repurposing market is growing with significant growth from last couple of years and in the year 2020, the market of Drug Repurposing was valued at USD XX Million and is expected to reach USD XXX million by the end of the year 2027. ,
The report is designed to offer very important and crucial information about the Drug Repurposing market and industry. For the purpose of this study, the market of Drug Repurposing has been segmented into type, application, regions and countries. Each segment of the report will provide a detailed analysis of the market and in terms of quantitative information, the report will offer market revenue (USD Million), market share in %, market CAGR from 2021 to 2027.
The report also provides a detailed qualitative analysis of the Drug Repurposing market which includes Market Drivers to explain the driving factors of the market and demand, Market Challenges to explain the restraints of the market and growth and Market Opportunities to explain the upcoming trends and opportunities left for the newcomers of the market and where can the existing companies focus in order to gain competitive advantage. The Drug Repurposing report also provides a detailed Porter's Five Forces, Micro and Macro Economic analysis which can help the readers and the users of the report to understand and draw a sound business decision.
The readers of the report will have a deep , insightful analysis that will help in understanding the market size, market share, CAGR, country specific analysis and market share for Drug Repurposing market.
Market Segmentation
One of the very important chapter of Drug Repurposing market report is competitive analysis. In this chapter, we have presented a detailed overview of the competition and have provided the market revenue of each company along with the market share.
The companies mentioned in the report are:
Astellas Pharma
Biovista
Novartis
AbbVie
Pfizer
Allergan
NuMedii
Note: We can also add companies which are not part of the above list
Global Drug Repurposing Market Analysis By Type
Oncology
CNS Diseases
Neurodegenerative Diseases
Others
In the year 2020, Oncology segment had XX% of market share and in terms of value, the Oncology market was valued at USD XX Million. , It is expected that Oncology will have XX% of market share by the end of year 2027 and the incremental growth from 2021 till 2027 is expected to be USD XX Million.
Global Drug Repurposing Market Analysis By Application
Hospitals
Ambulatory Surgical Centers
Others
Hospitals segment is expected to account for XX% of market share by the end of year 2027 from XX% in 2020. The Hospitals segment is expected to grow at USD XX million by the end of year 2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The following regions has been further bifurcated into countries to provide an insightful analysis for the readers.
Global Drug Repurposing market: regional analysis, the major regions covered in the report are:
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Drug Repurposing Market status and future forecast.
To present the key Drug Repurposing Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Frequently Asked Questions - FAQ:
How big is the opportunity for the Drug Repurposing market
What are the recent industry development that can be implemented to generate additional revenue streams
Who are the major players operating in the Drug Repurposing market Which companies are the front runners
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Drug Repurposing Market Size Growth Rate by Type (2021-2027)
1.3.2 Oncology
1.3.3 CNS Diseases
1.3.4 Neurodegenerative Diseases
1.3.5 Others
1.4 Market Segment by Application
1.4.1 Global Drug Repurposing Market Share by Application (2021-2027)
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Centers
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Repurposing Market Size
2.1.1 Global Drug Repurposing Revenue 2016-2027
2.1.2 Global Drug Repurposing Sales 2016-2027
2.2 Drug Repurposing Growth Rate by Regions
2.2.1 Global Drug Repurposing Sales by Regions 2016-2020
2.2.2 Global Drug Repurposing Revenue by Regions 2016-2020
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Drug Repurposing Sales by Manufacturers
3.1.1 Drug Repurposing Sales by Manufacturers 2016-2020
3.1.2 Drug Repurposing Sales Market Share by Manufacturers 2016-2020
3.2 Revenue by Manufacturers
3.2.1 Drug Repurposing Revenue by Manufacturers (2016-2020)
3.2.2 Drug Repurposing Revenue Share by Manufacturers (2016-2020)
3.2.3 Global Drug Repurposing Market Concentration Ratio (CR5 and HHI)
3.3 Drug Repurposing Price by Manufacturers
3.4 Key Manufacturers Drug Repurposing Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Drug Repurposing Market
3.6 Key Manufacturers Drug Repurposing Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Oncology Sales and Revenue (2016-2020)
4.1.2 CNS Diseases Sales and Revenue (2016-2020)
4.1.3 Neurodegenerative Diseases Sales and Revenue (2016-2020)
4.1.4 Others Sales and Revenue (2016-2020)
4.2 Global Drug Repurposing Sales Market Share by Type
4.3 Global Drug Repurposing Revenue Market Share by Type
4.4 Drug Repurposing Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Drug Repurposing Sales by Application
6 United States
6.1 United States Drug Repurposing Breakdown Data by Company
6.2 United States Drug Repurposing Breakdown Data by Type
6.3 United States Drug Repurposing Breakdown Data by Application
7 European Union
7.1 European Union Drug Repurposing Breakdown Data by Company
7.2 European Union Drug Repurposing Breakdown Data by Type
7.3 European Union Drug Repurposing Breakdown Data by Application
8 China
8.1 China Drug Repurposing Breakdown Data by Company
8.2 China Drug Repurposing Breakdown Data by Type
8.3 China Drug Repurposing Breakdown Data by Application
9 Rest of World
9.1 Rest of World Drug Repurposing Breakdown Data by Company
9.2 Rest of World Drug Repurposing Breakdown Data by Type
9.3 Rest of World Drug Repurposing Breakdown Data by Application
9.4 Rest of World Drug Repurposing Breakdown Data by Countries
9.4.1 Rest of World Drug Repurposing Sales by Countries
9.4.2 Rest of World Drug Repurposing Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Astellas Pharma
10.1.1 Astellas Pharma Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Drug Repurposing
10.1.4 Drug Repurposing Product Introduction
10.1.5 Astellas Pharma Recent Development
10.2 Biovista
10.2.1 Biovista Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Drug Repurposing
10.2.4 Drug Repurposing Product Introduction
10.2.5 Biovista Recent Development
10.3 Novartis
10.3.1 Novartis Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Drug Repurposing
10.3.4 Drug Repurposing Product Introduction
10.3.5 Novartis Recent Development
10.4 AbbVie
10.4.1 AbbVie Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Drug Repurposing
10.4.4 Drug Repurposing Product Introduction
10.4.5 AbbVie Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Drug Repurposing
10.5.4 Drug Repurposing Product Introduction
10.5.5 Pfizer Recent Development
10.6 Allergan
10.6.1 Allergan Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Drug Repurposing
10.6.4 Drug Repurposing Product Introduction
10.6.5 Allergan Recent Development
10.7 NuMedii
10.7.1 NuMedii Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Drug Repurposing
10.7.4 Drug Repurposing Product Introduction
10.7.5 NuMedii Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Drug Repurposing Sales Channels
11.2.2 Drug Repurposing Distributors
11.3 Drug Repurposing Customers
12 Market Forecast
12.1 Global Drug Repurposing Sales and Revenue Forecast 2021-2027
12.2 Global Drug Repurposing Sales Forecast by Type
12.3 Global Drug Repurposing Sales Forecast by Application
12.4 Drug Repurposing Forecast by Regions
12.4.1 Global Drug Repurposing Sales Forecast by Regions 2021-2027
12.4.2 Global Drug Repurposing Revenue Forecast by Regions 2021-2027
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Disclaimer
List of Tables and Figures
List of Tables and Figures
Figure Drug Repurposing Product Picture
Table Drug Repurposing Key Market Segments
Table Major Manufacturers Drug Repurposing Covered in This Report
Table Global Drug Repurposing Market Size Growth Rate by Type 2021-2027 (K MT) & (Million US$)
Figure Global Drug Repurposing Sales Market Shar by Type 2016-2027
Figure Oncology Figures
Table Major Manufacturers of Oncology
Figure CNS Diseases Figures
Table Major Manufacturers of CNS Diseases
Figure Neurodegenerative Diseases Figures
Table Major Manufacturers of Neurodegenerative Diseases
Figure Others Figures
Table Major Manufacturers of Others
Table Global Drug Repurposing Market Share by Application 2021-2027 (K MT)
Figure Hospitals Use Case
Figure Ambulatory Surgical Centers Use Case
Figure Others Use Case
Figure Drug Repurposing Report Years Considered
Figure Global Drug Repurposing Market Size 2016-2027 (Million US$)
Figure Global Drug Repurposing Sales 2016-2020 (K MT)
Table Global Drug Repurposing Market Size by Regions 2016-2020 (K MT) & (Million US$)
Table Global Drug Repurposing Sales by Regions 2016-2020 (K MT)
Table Global Drug Repurposing Sales Market Share by Regions 2016-2020
Figure Global Drug Repurposing Sales Market Share by Regions 2016-2020
Figure Global Drug Repurposing Sales Market Share by Regions in 2020
Table Global Drug Repurposing Revenue by Regions 2016-2020 (Million US$)
Table Global Drug Repurposing Revenue Market Share by Regions 2016-2020
Figure Global Drug Repurposing Revenue Market Share by Regions 2016-2020
Figure Global Drug Repurposing Revenue Market Share by Regions in 2020
Table Market Top Trends
Table Global Drug Repurposing Sales by Manufacturers (2016-2020) (K MT)
Table Global Drug Repurposing Sales Share by Manufacturers (2016-2020)
Figure Global Drug Repurposing Sales Share by Manufacturers in 2020
Table Drug Repurposing Revenue by Manufacturers (2016-2020) (Million USD)
Table Drug Repurposing Revenue Share by Manufacturers (2016-2020)
Figure Drug Repurposing Value Share by Manufacturers in 2020
Table Global Drug Repurposing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Drug Repurposing Price (2016-2020) (USD/MT)
Table Key Manufacturers Drug Repurposing Plants/Factories Distribution
Table Key Manufacturers Drug Repurposing Area Served
Table Date of Key Manufacturers Enter into Drug Repurposing Market
Table Key Manufacturers Drug Repurposing Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Oncology Sales and Revenue (2016-2020) (K MT) & (Million US$)
Table Global CNS Diseases Sales and Revenue (2016-2020) (K MT) & (Million US$)
Table Global Neurodegenerative Diseases Sales and Revenue (2016-2020) (K MT) & (Million US$)
Table Global Others Sales and Revenue (2016-2020) (K MT) & (Million US$)
Table Global Drug Repurposing Sales by Type (2016-2020) (K MT)
Table Global Drug Repurposing Sales Share by Type (2016-2020)
Figure Global Drug Repurposing Sales Market Share by Type (2016-2020)
Figure Global Drug Repurposing Sales Market Share by Type in 2020
Table Global Drug Repurposing Revenue by Type (2016-2020) (Million US$)
Table Global Drug Repurposing Revenue Share by Type (2016-2020)
Figure Global Drug Repurposing Revenue Market Share by Type (2016-2020)
Figure Global Drug Repurposing Revenue Market Share by Type in 2020
Table Drug Repurposing Price by Type 2016-2020 (USD/MT)
Table Global Drug Repurposing Sales by Application (2016-2020) (K MT)
Table Global Drug Repurposing Sales Share by Application (2016-2020)
Figure Global Sales Drug Repurposing Market Share by Application (2016-2020)
Figure Global Sales Drug Repurposing Market Share by Application (2016-2020)
Figure United States Drug Repurposing Sales Growth Rate 2016-2020 (K MT)
Figure United States Drug Repurposing Revenue Growth Rate 2016-2020 (Million US$)
Table United States Drug Repurposing Sales by Company (2016-2020) (K MT)
Table United States Drug Repurposing Sales Market Share by Company (2016-2020)
Figure United States Drug Repurposing Sales Market Share by Company in 2020
Table United States Drug Repurposing Sales by Type (2016-2020) (K MT)
Table United States Drug Repurposing Sales Market Share by Type (2016-2020)
Figure United States Drug Repurposing Market Share by Type in 2020
Table United States Drug Repurposing Sales by Application (2016-2020) (K MT)
Table United States Drug Repurposing Sales Market Share by Application (2016-2020)
Figure United States Drug Repurposing Market Share by Application in 2020
Figure European Union Drug Repurposing Sales Growth Rate 2016-2020 (K MT)
Figure European Union Drug Repurposing Revenue Growth Rate 2016-2020 (Million US$)
Table European Union Drug Repurposing Sales by Company (2016-2020) (K MT)
Table European Union Drug Repurposing Sales Market Share by Company (2016-2020)
Figure European Union Drug Repurposing Sales Market Share by Company in 2020
Table European Union Drug Repurposing Sales by Type (2016-2020) (K MT)
Table European Union Drug Repurposing Sales Market Share by Type (2016-2020)
Figure European Union Drug Repurposing Market Share by Type
Table European Union Drug Repurposing Sales by Application (2016-2020) (K MT)
Table European Union Drug Repurposing Sales Market Share by Application (2016-2020)
Figure European Union Drug Repurposing Market Share by Application
Figure China Drug Repurposing Sales Growth Rate 2016-2020 (K MT)
Figure China Drug Repurposing Revenue Growth Rate 2016-2020 (Million US$)
Table China Drug Repurposing Sales by Company (2016-2020) (K MT)
Table China Drug Repurposing Sales Market Share by Company (2016-2020)
Figure China Drug Repurposing Sales Market Share by Company in 2020
Table China Drug Repurposing Sales by Type (2016-2020) (K MT)
Table China Drug Repurposing Sales Market Share by Type (2016-2020)
Figure China Drug Repurposing Market Share by Type in 2020
Table China Drug Repurposing Sales by Application (2016-2020) (K MT)
Table China Drug Repurposing Sales Market Share by Application (2016-2020)
Figure China Drug Repurposing Market Share by Application in 2020
Figure Rest of World Drug Repurposing Sales Growth Rate 2016-2020 (K MT)
Figure Rest of World Drug Repurposing Revenue Growth Rate 2016-2020 (Million US$)
Table Rest of World Drug Repurposing Sales by Company (2016-2020) (K MT)
Table Rest of World Drug Repurposing Sales Market Share by Company (2016-2020)
Figure Rest of World Drug Repurposing Sales Market Share by Company in 2020
Table Rest of World Drug Repurposing Sales by Type (2016-2020) (K MT)
Table Rest of World Drug Repurposing Sales Market Share by Type (2016-2020)
Figure Rest of World Drug Repurposing Market Share by Type in 2020
Table Rest of World Drug Repurposing Sales by Application (2016-2020) (K MT)
Table Rest of World Drug Repurposing Sales Market Share by Application (2016-2020)
Figure Rest of World Drug Repurposing Market Share by Application in 2020
Table Rest of World Drug Repurposing Sales by Countries (2016-2020) (K MT)
Table Rest of World Drug Repurposing Sales Market Share by Countries (2016-2020)
Figure Rest of World Drug Repurposing Sales Market Share by Countries in 2020
Table Rest of World Drug Repurposing Revenue by Countries (2016-2020) (Million US$)
Table Rest of World Drug Repurposing Revenue Market Share by Countries (2016-2020)
Figure Rest of World Drug Repurposing Revenue Market Share by Countries in 2020
Figure Japan Drug Repurposing Sales Growth Rate (2016-2020) (K MT)
Figure Japan Drug Repurposing Revenue Growth Rate (2016-2020) (K MT)
Figure Korea Drug Repurposing Sales Growth Rate (2016-2020) (K MT)
Figure Korea Drug Repurposing Revenue Growth Rate (2016-2020) (K MT)
Figure India Drug Repurposing Sales Growth Rate (2016-2020) (K MT)
Figure India Drug Repurposing Revenue Growth Rate (2016-2020) (K MT)
Figure Southeast Asia Drug Repurposing Sales Growth Rate (2016-2020) (K MT)
Figure Southeast Asia Drug Repurposing Revenue Growth Rate (2016-2020) (K MT)
Table Astellas Pharma Company Details
Table Astellas Pharma Description and Business Overview
Table Astellas Pharma Drug Repurposing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2020)
Table Astellas Pharma Drug Repurposing Sales Growth Rate (2016-2020)
Table Astellas Pharma Drug Repurposing Sales Market Share in Global Market
Table Astellas Pharma Recent Development
Table Biovista Company Details
Table Biovista Description and Business Overview
Table Biovista Drug Repurposing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2020)
Table Biovista Drug Repurposing Sales Growth Rate (2016-2020)
Table Biovista Drug Repurposing Sales Market Share in Global Market
Table Biovista Recent Development
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis Drug Repurposing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2020)
Table Novartis Drug Repurposing Sales Growth Rate (2016-2020)
Table Novartis Drug Repurposing Sales Market Share in Global Market
Table Novartis Recent Development
Table AbbVie Company Details
Table AbbVie Description and Business Overview
Table AbbVie Drug Repurposing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2020)
Table AbbVie Drug Repurposing Sales Growth Rate (2016-2020)
Table AbbVie Drug Repurposing Sales Market Share in Global Market
Table AbbVie Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Drug Repurposing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2020)
Table Pfizer Drug Repurposing Sales Growth Rate (2016-2020)
Table Pfizer Drug Repurposing Sales Market Share in Global Market
Table Pfizer Recent Development
Table Allergan Company Details
Table Allergan Description and Business Overview
Table Allergan Drug Repurposing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2020)
Table Allergan Drug Repurposing Sales Growth Rate (2016-2020)
Table Allergan Drug Repurposing Sales Market Share in Global Market
Table Allergan Recent Development
Table NuMedii Company Details
Table NuMedii Description and Business Overview
Table NuMedii Drug Repurposing Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2020)
Table NuMedii Drug Repurposing Sales Growth Rate (2016-2020)
Table NuMedii Drug Repurposing Sales Market Share in Global Market
Table NuMedii Recent Development
Figure Drug Repurposing Value Chain
Table Drug Repurposing Distributors List
Table Drug Repurposing Customers List
Table Global Drug Repurposing Sales Forecast 2021-2027 (K MT) & (Million US$)
Figure Global Drug Repurposing Sales Forecast 2021-2027 (K MT)
Figure Global Drug Repurposing Revenue Forecast 2021-2027 (Million US$)
Table Global Drug Repurposing Sales Forecast by Type 2021-2027 (K MT)
Figure Global Drug Repurposing Sales Forecast by Type 2021-2027 (K MT)
Figure Global Drug Repurposing Sales Market Share Forecast by Type 2021-2027
Table Global Drug Repurposing Sales Forecast by Application 2021-2027 (K MT)
Figure Global Drug Repurposing Sales Forecast by Application 2021-2027 (K MT)
Figure Global Drug Repurposing Sales Market Share Forecast by Application 2021-2027
Table Global Drug Repurposing Sales Forecast by Regions 2021-2027 (K MT)
Figure Global Drug Repurposing Sales Forecast by Regions 2021-2027 (K MT)
Figure Global Drug Repurposing Sales Market Share Forecast by Regions 2021-2027
Table Global Drug Repurposing Revenue Forecast by Regions 2021-2027 (K MT)
Figure Global Drug Repurposing Revenue Forecast by Regions 2021-2027 (K MT)
Figure Global Drug Repurposing Revenue Market Share Forecast by Regions 2021-2027
Figure United States Drug Repurposing Sales Forecast 2021-2027 (K MT)
Figure United States Drug Repurposing Revenue Forecast 2021-2027 (Million US$)
Figure European Union Drug Repurposing Sales Forecast 2021-2027 (K MT)
Figure European Union Drug Repurposing Revenue Forecast 2021-2027 (Million US$)
Figure China Drug Repurposing Sales Forecast 2021-2027 (K MT)
Figure China Drug Repurposing Revenue Forecast 2021-2027 (Million US$)
Figure Japan Drug Repurposing Sales Forecast 2021-2027 (K MT)
Figure Japan Drug Repurposing Revenue Forecast 2021-2027 (Million US$)
Figure Korea Drug Repurposing Sales Forecast 2021-2027 (K MT)
Figure Korea Drug Repurposing Revenue Forecast 2021-2027 (Million US$)
Figure India Drug Repurposing Sales Forecast 2021-2027 (K MT)
Figure India Drug Repurposing Revenue Forecast 2021-2027 (Million US$)
Figure Southeast Asia Drug Repurposing Sales Forecast 2021-2027 (K MT)
Figure Southeast Asia Drug Repurposing Revenue Forecast 2021-2027 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation